This analysis evaluates NT proBNP as a potential marker or mediator of sarcopenia, suggesting diagnostic implications.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: